Amgen-AstraZeneca Combination Extends Survival in Lung Cancer Trial
A late-stage study found the drug combination lowered the risk of death and extended median survival for patients with extensive-stage disease.
Makkler Newsroom · Oct 24, 05:55 PM · 1 min read